Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Regulation of OTC...

    Regulation of OTC drugs : CDSCO to soon amend Schedule K of Drugs and Cosmetics Act

    Farhat NasimWritten by Farhat Nasim Published On 2019-09-21T15:21:09+05:30  |  Updated On 13 Aug 2021 3:15 PM IST

    The Sub-Committee is of the opinion that there is an urgent need for defining the Over-the-Counter (OTC) drugs and to lay down specific provisions for the regulation of OTC drugs in the country.


    New Delhi: The Drugs and Cosmetics Act may soon see an amendment in order to define and regularise the sale of over-the-counter drugs (OTC drugs), as the Drugs Consultative Committee of the Central Drugs Standard Control Organisation (CDSCO) was recently seen highlighting the need to this effect


    The Drugs Consultative Committee (DCC) functional under the apex drug regulatory body, Central Drugs Standard Control Organisation (CDSCO) considered recommendations to incorporate necessary provisions in the Drugs and Cosmetics Rules, 1945 for exempting OTC drugs from requirements of sale license or prescription of doctors.


    The DCC suggestion came after a sub-committee under the chairmanship of N.K. Ahuja, Drugs Controller, Haryana submitted its recommendations to this effect to the DCC. The Sub-Committee highlighted that there is an urgent need for defining the Over-the-Counter (OTC) drugs and to lay down specific provisions for the regulation of OTC drugs in the country. For these purposes following recommendations were suggested:


    Promote self-care without compromising patient safety thereby reducing the treatment cost.




    • The definition of OTC drug must be laid down in the Drugs & Cosmetics Rules, 1945

    • Basic Characteristics of OTC Drugs should be incorporated


    Classification of OTC drugs into OTC-1 and OTC-2 based on the extent of evidence of safety, therapeutic index, need for accessibility to patients, availability, non-habit forming nature, present supply chain mechanism, socioeconomic conditions of the country.




    • Initial list of OTC Drugs should be prepared

    • Regulation of switch of prescription Drugs to OTC Drug

    • Regulation of New OTC Drug Approval

    • Distribution & Sale of OTC Drugs

    • Advertisement of OTC Drugs


    After detailed deliberation, DCC recommended that the recommendations of the Subcommittee should be considered for suitable amendment in the Schedule K of the Drugs and Cosmetics Rules, 1945 to incorporate necessary provisions for such drugs for providing exemptions from requirements of Sale license/ prescription of RMP etc. subject to appropriate conditions.




    In terms of Rule 123, drugs listed in Schedule K of the Drugs and Cosmetics Rules, 1945, do not need a licence for sale if sold by shop other than a chemist's shop. Drugs in Schedule K include the following:





    • Drugs not intended for medicinal use



    • Quinine and other antimalarial drugs



    • Magnesium sulfate



    • Substances intended to be used for the destruction of vermin or insects, which cause disease in human beings or animals viz. Insecticides and Disinfectants.



    • Household remedies, namely:◊ Aspirin tablets◊ Paracetamol tablets◊ Analgesic balms◊ Antacid preparations◊ Gripe water for use of infants◊ Inhalers, containing drugs for the treatment of the cold and nasal congestion◊ Syrups, lozenges, pills and tablets for cough.◊ Liniments for external use◊ Skin ointments and ointments for burns◊ Absorbent cotton wool, bandages, absorbent gauze and adhesive plaster.◊ Castor oil, liquid Paraffin and Epsom salt.



    "Accordingly, the sub-committee should identify such list along with conditions and frame draft for amendments in the Rules, " DCC further recommended.


    Medical Dialogues had earlier reported that the Delhi High Court directed the Centre to provide a "partial list" of over the counter (OTC) drugs to doctors and pharmacists.


    Also Read: Delhi High Court directs Centre to provide a partial list of OTC drugs to doctors, pharmacists

    (DCC)AsprinCDSCOCentral Drugs Standard Control OrganisationDelhiDnC rulesdoctorsDrugs and Cosmetics RulesDrugs Consultative Committeedrugs rules 1945epsom saltHigh CourtOTCotc approved drugsOTC drugsParacetamolpharapharma newspharma news indiapharmacistsales licenseschedule K drugs

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Farhat Nasim
    Farhat Nasim

      Farhat Nasim joined Medical Dialogue an Editor for the Business Section in 2017. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate of St.Xavier’s College Ranchi. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751 To know about our editorial team click here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok